SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-17-013524
Filing Date
2017-12-21
Accepted
2017-12-21 15:58:26
Documents
4
Period of Report
2017-12-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k122117_immucellcorp.htm 8-K 31480
2 UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND CRAIG-HALLUM CAPITAL GROUP LLC, D f8k122117ex1-1_immucell.htm EX-1.1 196881
3 OPINION OF PIERCE ATWOOD LLP f8k122117ex5-1_immucell.htm EX-5.1 5212
4 PRESS RELEASE OF IMMUCELL CORPORATION DATED DECEMBER 21, 2017. f8k122117ex99-1_immucell.htm EX-99.1 16848
  Complete submission text file 0001213900-17-013524.txt   251478
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 171269462
SIC: 2835 In Vitro & In Vivo Diagnostic Substances